Chia-Wei Wang

Title: Innovations of Chia-Wei Wang

Introduction

Chia-Wei Wang is a notable inventor based in Santa Clara, CA, who has made significant contributions to the field of biotechnology. He holds three patents that focus on advanced polypeptide compositions and their applications in treating various medical conditions.

Latest Patents

One of his latest patents is titled "Extended recombinant polypeptides and compositions comprising same." This invention relates to compositions that include biologically active proteins linked to extended recombinant polypeptides (XTEN). It also encompasses isolated nucleic acids encoding these compositions, as well as vectors and host cells containing them. The methods described in this patent are aimed at treating glucose-related diseases, metabolic diseases, coagulation disorders, and growth hormone-related disorders.

Another significant patent by Wang is "Chimeric polypeptide assembly and methods of making and using the same." This invention involves bispecific chimeric polypeptide assembly compositions that comprise bulking moieties linked to binding domains by cleavable release segments. When cleaved, these segments can concurrently bind effector T cells with targeted tumor or cancer cells, leading to the cytolysis of the tumor or cancer cells. The patent also provides methods for making and using these cleavable chimeric polypeptide assembly compositions.

Career Highlights

Chia-Wei Wang has worked with prominent companies in the biotechnology sector, including Amunix Pharmaceuticals, Inc. and Bioverativ Therapeutics Inc. His work in these organizations has contributed to the advancement of therapeutic solutions in the medical field.

Collaborations

Wang has collaborated with notable professionals in his field, including Volker Schellenberger and Fan Yang, who is a distinguished woman in biotechnology.

Conclusion

Chia-Wei Wang's innovative work in recombinant polypeptides and chimeric polypeptide assemblies showcases his commitment to advancing medical treatments. His contributions are paving the way for new therapeutic approaches to complex diseases.